04:39 PM EST, 01/17/2025 (MT Newswires) -- Kyle Gano, Director, Chief Executive Officer, on January 15, 2025, sold 65,000 shares in Neurocrine Biosciences ( NBIX ) for $9,197,550. Following the Form 4 filing with the SEC, Gano has control over a total of 135,392 shares of the company, with 135,392 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/914475/000091447525000004/xslF345X05/wk-form4_1737149514.xml